Cargando…
Dynamic modulations of sphingolipids and glycerophospholipids in COVID‐19
BACKGROUND: A heterogeneous clinical phenotype is a characteristic of coronavirus disease 2019 (COVID‐19). Therefore, investigating biomarkers associated with disease severity is important for understanding the mechanisms responsible for this heterogeneity and for developing novel agents to prevent...
Autores principales: | Kurano, Makoto, Okamoto, Koh, Jubishi, Daisuke, Hashimoto, Hideki, Sakai, Eri, Saigusa, Daisuke, Kano, Kuniyuki, Aoki, Junken, Harada, Sohei, Okugawa, Shu, Doi, Kent, Moriya, Kyoji, Yatomi, Yutaka |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9549873/ https://www.ncbi.nlm.nih.gov/pubmed/36214754 http://dx.doi.org/10.1002/ctm2.1069 |
Ejemplares similares
-
Dynamic modulations of urinary sphingolipid and glycerophospholipid levels in COVID-19 and correlations with COVID-19-associated kidney injuries
por: Kurano, Makoto, et al.
Publicado: (2022) -
Sphingosine 1‐phosphate lyase facilitates cancer progression through converting sphingolipids to glycerophospholipids
por: Uranbileg, Baasanjav, et al.
Publicado: (2022) -
Decrease in serum levels of autotaxin in COVID-19 patients
por: Shimura, Takuya, et al.
Publicado: (2022) -
Increase in serum levels of phosphatidylserine-specific phospholipase A(1) in COVID-19 patients
por: Shimura, Takuya, et al.
Publicado: (2021) -
Clot waveform of APTT has abnormal patterns in subjects with COVID-19
por: Shimura, Takuya, et al.
Publicado: (2021)